1. Home
  2. CLOV vs TMDX Comparison

CLOV vs TMDX Comparison

Compare CLOV & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

N/A

Current Price

$5.01

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

N/A

Current Price

$92.24

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLOV
TMDX
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
CLOV
TMDX
Price
$5.01
$92.24
Analyst Decision
Buy
Buy
Analyst Count
5
13
Target Price
$5.60
★ $104.55
AVG Volume (30 Days)
★ 4.2M
1.1M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
38.03
★ 382.18
EPS
0.11
★ 1.08
Revenue
★ $1,924,308,000.00
$605,494,000.00
Revenue This Year
$55.33
$26.63
Revenue Next Year
$22.64
$17.56
P/E Ratio
★ $44.68
$84.63
Revenue Growth
★ 40.34
37.13
52 Week Low
$1.58
$60.11
52 Week High
$5.59
$156.00

Technical Indicators

Market Signals
Indicator
CLOV
TMDX
Relative Strength Index (RSI) 60.60 67.07
Support Level $4.17 $65.51
Resistance Level $5.09 $92.93
Average True Range (ATR) 0.28 4.70
MACD 0.04 3.29
Stochastic Oscillator 75.12 83.32

Price Performance

Historical Comparison
CLOV
TMDX

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: